I-cell cultured fibroblasts secrete excessive amounts of N-acetyl-fl-D-hexosaminidase and a -L-fucosidase into the culture media as compared with normal fibroblasts. Addition of tunicamycin or cycloheximide at doses that inhibit the incorporation of [3Hlmannose (60-80%) and [14C]leucine (40-50%) into trichloroacetic acid-precipitable material decreased the secretion of these I-cell hydrolases to normal values within 24h, but had no effect on the secretion of acid hydrolases from normal fibroblasts. These results indicate that I-cell cultured fibroblasts secrete at least two types of acid hydrolases: one is tunicamycin-and cycloheximide-sensitive and constitutes the greater proportion of the secreted hydrolases, and a smaller proportion is insensitive to tunicamycin and cycloheximide, similar to the acid hydrolases secreted by normal cultured fibroblasts.
a -L-fucosidase into the culture media as compared with normal fibroblasts. Addition of tunicamycin or cycloheximide at doses that inhibit the incorporation of [3Hlmannose (60-80%) and [14C] leucine (40-50%) into trichloroacetic acid-precipitable material decreased the secretion of these I-cell hydrolases to normal values within 24h, but had no effect on the secretion of acid hydrolases from normal fibroblasts. These results indicate that I-cell cultured fibroblasts secrete at least two types of acid hydrolases: one is tunicamycin-and cycloheximide-sensitive and constitutes the greater proportion of the secreted hydrolases, and a smaller proportion is insensitive to tunicamycin and cycloheximide, similar to the acid hydrolases secreted by normal cultured fibroblasts.
I-cell disease is a lysosomal storage disorder characterized in part by decreased activities of multiple acid hydrolases in cultured fibroblasts, with concomitant increases of many of these enzyme activities in the fibroblast media (Leroy et al., 1972; Hickman & Neufeld, 1972; Weismann & Herschkowitz, 1974) . This apparent mislocalization of the acid hydrolases and the autosomal recessive mode of inheritance suggest a single gene defect in I-cell disease that is common to the final expression of acid hydrolases. The molecular basis for this disorder is not known, but evidence from several laboratories indicates that the genetic defect results in an altered oligosaccharide side chain on the I-cell acid hydrolases (Hickman et al., 1974; . This altered carbohydrate may interfere with the ability of the hydrolases to be efficiently localized within the lysosome, and as a result the I-cell hydrolases are secreted to the extracellular media.
To investigate the role of hydrolase-bound carbohydrate in the localization of these enzymes within the lysosome, cultured fibroblasts from patients with I-cell disease, pseudo-Hurler polydystrophy (a variant of I-cell disease) and GM -gangliosidosis and normal control cultured fibroblasts were incubated with tunicamycin, an antibiotic which inhibits the formation of a dolichol-oligosaccharide intermediate involved in the glycosylation of asparaginelinked glycoproteins (Takatsuki & Tamura, 1971; Takatsuki et al., 1976 were added to each dish. At specified time intervals the medium was removed, the cells were washed twice with 0.5 ml of 0.85% (w/v) NaCl and incubated at room temperature for 30min with 1 ml of 0.5% (v/v) Nonidet P40 containing 1mg of nonradioactive leucine/ml. The lysed cells were harvested with a rubber policeman and the residual cells were harvested with an additional 0.5 ml of 0.5% Nonidet P-40 solution. The cell lysates were combined and centrifuged in a Beckman TJ-6 centrifuge at 850g for 10min at room temperature. The supernatant was removed, and the cell pellet was resuspended in 0.5ml of 0.5% Nonidet P-40 and re-centrifuged as described above. The two supernatants were pooled, human serum albumin was added as a carrier (final concn. 1 mg/ml) and the proteins were precipitated with an equal volume of cold 15% (w/v) trichloroacetic acid. This mixture was vortex-mixed and centrifuged in a Sorvall RC-5B centrifuge at 12500rev./min for 15min at 0-40C in a SM-24 rotor. The pellet was resuspended in 1ml of cold 7.5% trichloroacetic acid, vortex-mixed and recentrifuged as described above. The resultant precipitate was redissolved in 1 ml of 2% (w/v) Na2CO3/0.4% (w/v) NaOH/0.02% (w/v) sodium tartarate/0.01% (w/v) CuS04. Concentrated HCl (0.1 ml) and 8 ml of Biofluor (New England Nuclear) were added to 0.5 ml portions of the redissolved precipitate and the mixture was counted for radioNormal 1-cell activity in a Beckman LS8 100 scintillation counter. Protein determination on the cells was by the method of Lowry et al. (1951) , with bovine serum albumin as a standard.
Determination ofenzyme activity
The cultured fibroblasts were incubated as described above, without [3Hlmannose and ['4C]leucine. The intracellular and extracellular lysosomal hydrolase activities were determined in the presence and absence of tunicamycin or cycloheximide. At the specified times the medium was removed and used directly for enzyme assays. The intracellular enzymic activities were determined after washing the cells once with 0.5 ml of 0.85% NaCl, harvesting with 3 ml of 0.85% NaCl, and centrifuging the cells at 850g in the Beckman centrifuge (as above) for 5 min. The resulting cell pellet was resuspended in 0.1 ml of glass-distilled water and the suspension sonicated twice (Kontes micro-ultrasonic cell disrupter, setting 5) for lOs with a 1Os interval between pulses. fI-D-Hexosaminidase and a-L-fucosidase activities were assayed fluorimetrically as previously described (Leroy et al., 1972; Alhadeff et al., 1974) .
The tunicamycin-and cycloheximide-treated cultured fibroblasts were found to be 95-100% viable, as determined by staining with a 0.5% (w/v) solution of Trypan Blue (Phillips, 1973) .
Results
Fig The enhanced secretion rate of f-D-hexosaminidase and a-L-fucosidase activities from I-cell cultured fibroblasts was decreased to normal values within 24 h in the presence of 1.0pg of tunicamycin/ml (Figs. 2b and 2d) . However, secretion of these enzymes from normal cells was not significantly affected by the same concentration of tunicamycin (Figs. 2a and 2c) . When higher concentrations of tunicamycin were used (2-3 ug/ml), no further decrease in the rate of secretion was seen for either the I-cell or normal fibroblasts (A. L. Miller, B. C. Kress, L. Lewis, R. Stein & C. Kinnon, unpublished work).
Because of the relatively high degrees of inhibition of protein synthesis by tunicamycin, studies were carried out to investigate whether the effects observed on I-cell enzyme secretion could be mimicked by using the protein-synthesis inhibitor cycloheximide. Cells were treated with concen- (Figs. 3c and 3d ), but there was no significant effect on the specific activity of this enzyme in normal fibroblasts (Figs. 3a and 3b ).
Similar studies with tunicamycin and cycloheximide were carried out on skin fibroblasts from patients with pseudo-Hurler polydystrophy and GM,-gangliosidosis. The results were similar to those for I-cell and normal fibroblasts respectively (results not shown).
Discussion
Cultured fibroblasts from patients with I-cell disease demonstrate increased acid hydrolase activities in the culture media as compared with normal fibroblasts (Hickman & Neufeld, 1972; Hickman et al., 1974; Weismann & Herschkowitz, 1974) . The present studies demonstrate that this increase in hydrolase activities in the culture media is due to an enhanced rate of enzyme secretion from the I-cell fibroblasts. Furthermore, our results suggest that the acid hydrolase activities secreted from I-cell fibroblasts consist of at least two types of enzyme: (1) the greater proportion of the acid hydrolase activity is tunicamycin-and cycloheximide-sensitive and is, in this regard, unlike the acid hydrolases secreted from normal fibroblasts; and (2) a smaller proportion of the secreted hydrolases from I-cell fibroblasts is relatively insensitive to the effects of tunicamycin and cycloheximide, similar to the hydrolases secreted from normal fibroblasts. This differential effect of tunicamycin and cycloheximide on hydrolase secretion from I-cell and normal fibroblasts suggests that the increased rate of secretion of the I-cell hydrolases may be via an alternative pathway to the predominant one in normal fibroblasts. It is likely that less of the total I-cell enzyme synthesized at any one time is localized within the lysosome compared with normal controls. This may be due to an altered or absent carbohydrate recognition marker on the I-cell hydrolases necessary for their localization within the lysosome (Hickman et al., 1974) . As a result of their inability to be localized within lysosomes, the I-cell hydrolases are secreted to the extracellular milieu, possibly via the Golgi apparatus in a manner similar to other secreted glycoproteins (Zagury et al., 1970) . The basal rate of secretion observed for normal hydrolases, most of which are presumably localized within the lysosome, may result from lysosomal fusion with the plasma membrane (de Duve & Wattiaux, 1966; Lloyd, 1977; Von Figura & Weber, 1978) . This interpretation implies the existence of separate secretion pathways of the I-cell and normal hydrolases from cultured fibroblasts. An alternative interpretation may be that the enzymes from both cell types are secreted via similar pathways, but other regulatory mechanisms may be involved that respond differently to tunicamycin and cycloheximide in I-cell and normal fibroblasts. Our present data do not differentiate between these possibilities.
Treatment of cells with tunicamycin or cycloheximide for up to 24 h resulted in a decrease in the intracellular specific activity of /J-D>hexosaminidase activity for I-cell fibroblasts, whereas there was no effect on normal cells. It has been reported by others that treatment of rat embryo fibroblasts with cycloheximide (20,g/ml) for up to 4 days had no significant effect on the specific activities of intracellular acid phosphatase and f,-D-glucuronidase (Amenta et al., 1977 (Amenta et al., , 1978 . These data support the concept that in normal cells the greater proportion of these enzymes are probably packaged within the lysosome, whereas most of the intracellular I-cell acid hydrolases are probably not associated with the lysosomes. Finally, we have shown in this study that the effects of tunicamycin in cultured fibroblasts could be mimicked with cycloheximide. This should add caution to the interpretation of data obtained by using agents such as tunicamycin which have secondary effects on other cellular mechanisms.
